company background image
4153 logo

DIVA Laboratories TPEX:4153 Stock Report

Last Price

NT$43.70

Market Cap

NT$2.6b

7D

24.3%

1Y

14.8%

Updated

16 Apr, 2025

Data

Company Financials

4153 Stock Overview

Engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. More details

4153 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

DIVA Laboratories, Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DIVA Laboratories
Historical stock prices
Current Share PriceNT$43.70
52 Week HighNT$55.80
52 Week LowNT$31.30
Beta0.20
1 Month Change12.20%
3 Month Change16.22%
1 Year Change14.85%
3 Year Change70.70%
5 Year Change39.15%
Change since IPO165.19%

Recent News & Updates

Recent updates

Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

Feb 28
Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Dec 27
DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Nov 30
Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Shareholder Returns

4153TW ElectronicTW Market
7D24.3%10.0%7.6%
1Y14.8%-7.4%-1.5%

Return vs Industry: 4153 exceeded the TW Electronic industry which returned -7.4% over the past year.

Return vs Market: 4153 exceeded the TW Market which returned -1.5% over the past year.

Price Volatility

Is 4153's price volatile compared to industry and market?
4153 volatility
4153 Average Weekly Movement5.4%
Electronic Industry Average Movement7.9%
Market Average Movement7.4%
10% most volatile stocks in TW Market10.3%
10% least volatile stocks in TW Market4.9%

Stable Share Price: 4153 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4153's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995n/aZhiheng Zhaowww.diva.com.tw

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers video solutions.

DIVA Laboratories, Ltd. Fundamentals Summary

How do DIVA Laboratories's earnings and revenue compare to its market cap?
4153 fundamental statistics
Market capNT$2.56b
Earnings (TTM)NT$93.66m
Revenue (TTM)NT$862.32m

27.4x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4153 income statement (TTM)
RevenueNT$862.32m
Cost of RevenueNT$602.14m
Gross ProfitNT$260.18m
Other ExpensesNT$166.52m
EarningsNT$93.66m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.60
Gross Margin30.17%
Net Profit Margin10.86%
Debt/Equity Ratio0%

How did 4153 perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

125%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/16 22:46
End of Day Share Price 2025/04/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DIVA Laboratories, Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
Hsiu Chi LinMasterlink Securities Corp.